Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 9 | 9 |
| 2018 | 1 | 3 | 4 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 5 | 5 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 3 | 3 |
| 2024 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Prevalence of the cefazolin inoculum effect (CzIE) in nasal colonizing methicillin-susceptible Staphylococcus aureus in patients from intensive care units in Colombia and use of a modified rapid nitrocefin test for detection. Antimicrob Agents Chemother. 2024 11 06; 68(11):e0089824.
-
In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2024 Sep; 38:252-255.
-
Alternative iron-depleted media for cefiderocol susceptibility testing. Int J Antimicrob Agents. 2024 Jul; 64(1):107193.
-
Comparison of cefiderocol in-vitro susceptibility testing modalities. J Glob Antimicrob Resist. 2024 Jun; 37:100-101.
-
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 03 06; 68(3):e0162123.
-
The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy. Antimicrob Agents Chemother. 2024 01 10; 68(1):e0100923.
-
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE)?bloodstream infections. Int J Antimicrob Agents. 2023 Apr; 61(4):106760.
-
Growth of Acinetobacter baumannii impacted by iron chelation. Lett Appl Microbiol. 2023 Feb 16; 76(2).
-
Nonhydrolyzable d-phenylalanine-benzoxazole derivatives retain antitubercular activity. Bioorg Med Chem Lett. 2023 01 15; 80:129116.
-
Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii. Virulence. 2022 Dec; 13(1):1920-1927.